187 related articles for article (PubMed ID: 34636896)
21. Long-term safety of recombinant human growth hormone in children.
Bell J; Parker KL; Swinford RD; Hoffman AR; Maneatis T; Lippe B
J Clin Endocrinol Metab; 2010 Jan; 95(1):167-77. PubMed ID: 19906787
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
Pawlikowska-Haddal A
Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
[TBL] [Abstract][Full Text] [Related]
23. Predictors and growth consequences of central hypothyroidism in pediatric patients receiving recombinant human growth hormone.
Wong K; Levitsky LL; Misra M
J Pediatr Endocrinol Metab; 2010 May; 23(5):451-61. PubMed ID: 20662344
[TBL] [Abstract][Full Text] [Related]
24. Recent updates on recombinant human growth hormone outcomes and adverse events.
Watson SE; Rogol AD
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):39-43. PubMed ID: 23183360
[TBL] [Abstract][Full Text] [Related]
25. Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy.
Wit JM; Deeb A; Bin-Abbas B; Al Mutair A; Koledova E; Savage MO
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):329-340. PubMed ID: 31284701
[TBL] [Abstract][Full Text] [Related]
26. Treatment of growth hormone deficiency in children, adolescents and at the transitional age.
Richmond E; Rogol AD
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):749-755. PubMed ID: 27974188
[TBL] [Abstract][Full Text] [Related]
27. Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics.
Albertsson-Wikland K; Mårtensson A; Sävendahl L; Niklasson A; Bang P; Dahlgren J; Gustafsson J; Kriström B; Norgren S; Pehrsson NG; Odén A
J Clin Endocrinol Metab; 2016 May; 101(5):2149-59. PubMed ID: 26918292
[TBL] [Abstract][Full Text] [Related]
28. Adverse effects of growth hormone replacement therapy in children.
Souza FM; Collett-Solberg PF
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):559-65. PubMed ID: 22218437
[TBL] [Abstract][Full Text] [Related]
29. Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity.
Tidblad A; Bottai M; Kieler H; Albertsson-Wikland K; Sävendahl L
JAMA Pediatr; 2021 Feb; 175(2):e205199. PubMed ID: 33346824
[TBL] [Abstract][Full Text] [Related]
30. Safety of growth hormone treatment of children with idiopathic short stature: the US experience.
Allen DB
Horm Res Paediatr; 2011; 76 Suppl 3():45-7. PubMed ID: 21912165
[TBL] [Abstract][Full Text] [Related]
31. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
[TBL] [Abstract][Full Text] [Related]
32. Therapy of growth disorders.
Ali O; Wyatt D
Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
[TBL] [Abstract][Full Text] [Related]
33. Glucose Metabolism Evaluated by Glycated Hemoglobin and Insulin Sensitivity Indices in Children Treated with Recombinant Human Growth Hormone.
Pellegrin MC; Michelon D; Faleschini E; Germani C; Barbi E; Tornese G
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):350-357. PubMed ID: 30819016
[TBL] [Abstract][Full Text] [Related]
34. Indications for growth hormone therapy in children.
Kirk J
Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
[TBL] [Abstract][Full Text] [Related]
35. Testicular Growth and Pubertal Onset in GH-Deficient Children Treated With Growth Hormone: A Retrospective Study.
Cannarella R; Caruso M; Crafa A; Timpanaro TA; Lo Bianco M; Presti S; Condorelli RA; La Vignera S; Calogero AE
Front Endocrinol (Lausanne); 2021; 12():619895. PubMed ID: 33868165
[TBL] [Abstract][Full Text] [Related]
36. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
37. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
38. [Use of recombinant Human Growth Hormone (rHGH)].
Calzada-León R
Rev Med Inst Mex Seguro Soc; 2017; 55(2):196-213. PubMed ID: 28296370
[TBL] [Abstract][Full Text] [Related]
39. MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.
Boguszewski CL; Barbosa EJL; Svensson PA; Johannsson G; Glad CAM
Eur J Endocrinol; 2017 Dec; 177(6):R309-R321. PubMed ID: 28904008
[TBL] [Abstract][Full Text] [Related]
40. [Recommendations for the clinical use of recombinant human growth hormone in children].
; ; ; ;
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):426-32. PubMed ID: 24120059
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
